Spliceosome integrity is defective in the motor neuron diseases ALS and SMA

H Tsuiji, Y Iguchi, A Furuya, A Kataoka… - EMBO molecular …, 2013 - embopress.org
H Tsuiji, Y Iguchi, A Furuya, A Kataoka, H Hatsuta, N Atsuta, F Tanaka, Y Hashizume…
EMBO molecular medicine, 2013embopress.org
Two motor neuron diseases, amyotrophic lateral sclerosis (ALS) and spinal muscular
atrophy (SMA), are caused by distinct genes involved in RNA metabolism, TDP‐43 and
FUS/TLS, and SMN, respectively. However, whether there is a shared defective mechanism
in RNA metabolism common to these two diseases remains unclear. Here, we show that
TDP‐43 and FUS/TLS localize in nuclear Gems through an association with SMN, and that
all three proteins function in spliceosome maintenance. We also show that in ALS, Gems are …
Abstract
Two motor neuron diseases, amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), are caused by distinct genes involved in RNA metabolism, TDP‐43 and FUS/TLS, and SMN, respectively. However, whether there is a shared defective mechanism in RNA metabolism common to these two diseases remains unclear. Here, we show that TDP‐43 and FUS/TLS localize in nuclear Gems through an association with SMN, and that all three proteins function in spliceosome maintenance. We also show that in ALS, Gems are lost, U snRNA levels are up‐regulated and spliceosomal U snRNPs abnormally and extensively accumulate in motor neuron nuclei, but not in the temporal lobe of FTLD with TDP‐43 pathology. This aberrant accumulation of U snRNAs in ALS motor neurons is in direct contrast to SMA motor neurons, which show reduced amounts of U snRNAs, while both have defects in the spliceosome. These findings indicate that a profound loss of spliceosome integrity is a critical mechanism common to neurodegeneration in ALS and SMA, and may explain cell‐type specific vulnerability of motor neurons.
embopress.org